|
ICU admissions with LOS of ≥48 h
|
N = 1496
| |
N = 1444
| | |
|
First or re-admission
|
|
Primary admissions
|
1351
|
90.3%
|
1307
|
90.5%
|
0.85
|
|
Re-admissions
|
145
|
9.7%
|
137
|
9.5%
| |
|
Age, median (IQR)
|
62
|
[50–70]
|
63
|
[52–71]
|
0.07
|
|
Male sex, n (%)
|
890
|
59.5%
|
856
|
59.4%
|
0.94
|
|
BMI, mean (SD)
|
26.1
|
5.3
|
26.3
|
5.2
|
0.31
|
|
ICU mortality, n (%)
|
174
|
11.6%
|
146
|
10.1%
|
0.19
|
|
Hospital mortality, n (%)
|
225
|
15.0%
|
207
|
14.3%
|
0.59
|
|
ICU Lenght of stay (LOS), median days (IQR)
|
3
|
[2–6]
|
3
|
[2–6]
|
0.90
|
|
ICU LOS, n (%)
|
|
2 days
|
674
|
45.1%
|
653
|
45.2%
|
0.38
|
|
3–4 days
|
355
|
23.7%
|
351
|
24.3%
| |
|
5–6 days
|
127
|
8.5%
|
113
|
7.8%
| |
|
7–9 days
|
106
|
7.1%
|
94
|
6.5%
| |
|
10–13 days
|
81
|
5.4%
|
60
|
4.2%
| |
|
≥ 14 days
|
153
|
10.2%
|
173
|
12.0%
| |
|
Apache score, mean (SD)
|
18.7
|
7.2
|
18.2
|
7.2
|
0.27
|
|
Days on respirator, median (IQR)
|
2
|
[0–4]
|
1
|
[0–4]
|
0.38
|
|
Comorbidity at ICU admission, n ‘yes’ (%)
|
|
Any comorbidity
|
573
|
38.3%
|
504
|
34.9%
|
0.06
|
|
Cardiovascular insufficiency
|
93
|
6.2%
|
70
|
4.8%
|
0.11
|
|
Respiratory insufficiency
|
116
|
7.8%
|
71
|
4.9%
|
0.002
|
|
Diabetes
|
180
|
12.0%
|
168
|
11.6%
|
0.74
|
|
Chronic renal insufficiency
|
97
|
6.5%
|
83
|
5.7%
|
0.41
|
|
Neoplasm
|
130
|
8.7%
|
112
|
7.8%
|
0.36
|
|
Immune-insufficiency
|
166
|
11.1%
|
166
|
11.5%
|
0.93
|
|
Medical specialty, n (%)
|
|
Surgery
|
330
|
22.1%
|
361
|
25.0%
|
0.04
|
|
Neurosurgery
|
239
|
16.0%
|
200
|
13.9%
| |
|
Thoracic surgery
|
234
|
15.6%
|
245
|
17.0%
| |
|
Pulmonary disease
|
125
|
8.4%
|
139
|
9.6%
| |
|
Internal medicine
|
64
|
4.3%
|
72
|
5.0%
| |
|
Other
|
504
|
33.7%
|
427
|
29.6%
| |
|
Admission type, n (%)
|
|
Medical
|
732
|
48.9%
|
712
|
49.3%
|
0.06
|
|
Elective
|
528
|
35.3%
|
464
|
32.1%
| |
|
Emergency
|
236
|
15.8%
|
268
|
18.6%
| |
|
Admission source, n (%)
|
|
Emergency
|
372
|
24.9%
|
344
|
23.8%
|
0.27
|
|
Clinical department
|
292
|
19.5%
|
302
|
20.9%
| |
|
Other IC unit
|
93
|
6.2%
|
69
|
4.8%
| |
|
Other
|
739
|
49.4%
|
729
|
50.5%
| |
